Dalrada Financial Corporation
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Brian Bonar
- Full Time Employees
- 56
- Sector
- Industrials
- Industry
- Consulting Services
- Address
- 600 La Terraza Boulevard Escondido CA United States of America 92025
- IPO Date
- Jan 8, 2021
- CIK
- 0000725394
- Website
- dalrada.com
- Similar Companies
- Business
- Dalrada Financial Corporation (OTC: DFCO) is a publicly traded multinational holding company headquartered in Escondido, California, and founded in 1982 that develops, manufactures and sells products and services addressing climate change, healthcare gaps and advanced manufacturing needs; it operates through key subsidiaries including Dalrada Climate Technology, which provides commercial and residential heat pumps for energy efficiency and emissions reduction; DepTec (Deposition Technology), which specializes in physical vapor deposition equipment such as the EVOS PVD and CVD series, C1 Controller Upgrade Kit and Spectroptix plasma spectrometer for semiconductor, clean energy and precision manufacturing applications across industries like automotive, aerospace and pharmaceuticals; and Genefic Specialty Pharmacy, which offers end-to-end prescription fulfillment, patient advocacy, infusion services, biologics, biosimilars, telemedicine and weight loss programs targeting rare and complex conditions. The company maintains global operations with facilities in the United States (California, Alabama, Nevada), Scotland, Spain, India, and recently Morocco. Recent developments include the establishment of a new U.S. Portland facility for Deposition Technology to accelerate North American production and sales; the launch of Spectroptix for advance ordering; the formation of Dalrada Home Corporation in 2024 for home electrification integrating heat pumps, solar and battery systems; exclusive master distribution agreements for heat pumps with Applied Technologies of New York targeting 600 units and Onet Group in France; the acquisition of IV Services infusion pharmacy by Genefic entering the $42 billion market; selection of CM3 Advisory as new PCAOB auditor; addition of Roger Campos to the board; and CEO Brian Bonar receiving San Diego Business Journal's CEO of the Year award in 2024.
Critical Survey: DCC (OTCMKTS:DCCPF) and Dalrada Financial (OTCMKTS:DFCO)
Dalrada Technology Group, Inc. Shareholder Letter from the Chairman and CEO, Brian Bonar
Head-To-Head Survey: Healthcare Services Group (NASDAQ:HCSG) and Dalrada Financial (OTCMKTS:DFCO)
Dalrada Technology Group, Inc. Announces Ticker Symbol and Name Change
Dalrada Financial Corporation's Deposition Technology Makes Spectroptix(R) Available for Advance Ordering
Dalrada Financial Corporation Announces the Addition of Roger Campos to Its Board of Directors
Dalrada Financial Corporation establishes Deposition Technology Inc. U.S. Presence with new Portland Facility
Dalrada Financial Corporation Selects CM3 Advisory as Independent Registered Public Accounting Firm
Dalrada Financial Corporation Provides Update on Selection of New PCAOB Auditing Firm
Dalrada Financial Corporation CEO Appoints Pauline Gourdie as Chief of Staff
Dalrada Financial Corporation Signs Contract with France-Based Onet Group for Heat Pump Installation in Light Industrial Facility
Dalrada Financial Corporation Finalizes Exclusive Master Distribution Agreement with Applied Technologies of New York
CEO of Dalrada Financial Corporation Subsidiary, Genefic, Inc. Discusses Revenue Drivers and Growth in New Interview
Dalrada's Brian Bonar Wins San Diego Business Journal's CEO of the Year
Dalrada Financial Corporation CEO Discusses Increased Corporate Momentum and Shares Company Updates in New Interview
Dalrada Financial Corporation Healthcare Subsidiary, Genefic, Inc., Acquires IV Services Infusion Pharmacy
Dalrada Financial Corporation Files Form 10-Q, Announces Third Quarter Revenue of $10.3 Million
Dalrada Financial Corporation's Wholly-Owned Subsidiary, Genefic, Inc. Announces New Telemedicine Services, Enters Booming Weight Loss Drug Market
Dalrada Financial Corporation Subsidiary, Dalrada Home Corp., forms Advisory Board and Announces Inaugural Members
Dalrada Financial Corporation Enters $104 Billion Carbon Credit Market with Data Mining Innovation